What is WuXi Biologics (2269)?
WuXi Biologics is a global contract research, development, and manufacturing organization (CDMO) specializing in biologics. The company provides end-to-end solutions for the development and production of biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and vaccines. WuXi Biologics operates advanced manufacturing facilities and offers services spanning from cell line development to commercial manufacturing. Its integrated platform supports clients across various stages of drug development, facilitating efficient and scalable biologics production. The company serves a diverse client base, including pharmaceutical and biotechnology firms worldwide. WuXi Biologics focuses on innovation, quality control, and regulatory compliance to meet industry standards and accelerate the availability of biologic therapies.
WuXi Biologics Stock Price Today: Live Overview
The price today is shaped by current market fluctuations, with WuXi Biologics trading at HK$34.80. During the session, its price ranged from HK$33.55 to HK$34.55, indicating a daily change of -0.7289%.
FAQ: WuXi Biologics (2269)
What is the current price of 2269 stock?
WuXi Biologics' current price stands at HK$34.80.
Does 2269 pay dividends?
The company does not pay dividends.
Does 2269 have a formal corporate presence or regional headquarters in the UAE?
WuXi Biologics has a registered presence in Dubai Internet City, UAE.
What is 2269 best known for?
WuXi Biologics is most famous for its contract biopharmaceutical manufacturing services.
What assets are typically shown together with 2269?
Commonly shown alongside 2269: SPDR MSCI Europe Energy UCITS ETF, Intuitive Investments Group PLC, Roche Holding AG (Bearer)
Latest shares articles



